Some Observations on the Rôle of Hageman Factor in Blood Coagulation

C Haanen; F Hommes; Gerdy Morselt

doi:10.1055/s-0038-1654559

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1961; 6(02): 261-269
DOI: 10.1055/s-0038-1654559

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Some Observations on the Rôle of Hageman Factor in Blood Coagulation

C Haanen

¹Department of Medicine of St. Radboud Hospital, University of Nijmegen, The Netherlands (Head: Prof. Dr. C. L. H. Major), Institute of Biochemistry, University of Nijmegen, The Netherlands (Head: Prof. Dr. F. W. Zilliken)

,

F Hommes

¹Department of Medicine of St. Radboud Hospital, University of Nijmegen, The Netherlands (Head: Prof. Dr. C. L. H. Major), Institute of Biochemistry, University of Nijmegen, The Netherlands (Head: Prof. Dr. F. W. Zilliken)

,

Gerdy Morselt

¹Department of Medicine of St. Radboud Hospital, University of Nijmegen, The Netherlands (Head: Prof. Dr. C. L. H. Major), Institute of Biochemistry, University of Nijmegen, The Netherlands (Head: Prof. Dr. F. W. Zilliken)

› Author Affiliations

Abstract

Summary

The defective thromboplastin formation in Hageman factor deficient plasma is completely corrected using incubation tubes which have been coated previously with normal plasma. Positively or negatively charged molecules as protamin and sulphated polysaccharides interfere with this correction in a way that gives evidence Hageman factor is a positively charged protein.

The defective thromboplastin generation of Hageman factor deficient incubation mixtures is corrected by addition of a purified Hageman factor preparation. Pre-incubation of Hageman factor with HF deficient serum improves the thromboplastin formation further, while pre-incubation of Hageman factor with HF deficient plasma abolishes this correction complete. Possibly here lies the key for the fact that serum clotting factors augment and plasma factors deteriorate during the clotting process.

Full Text

References

References
1 Alexander B, de Vries A, Goldstein R. A factor in serum which accelerates the conversion of prothrombin to thrombin. Blood 4: 739 1949;
2 Bachmann F, Duckert F, Koller F. The Stuart-Prower Factor Assay and its clinical Significance. Thromb. Diath. haem. 2: 24 1958;
3 Becker E. L. Inactivation of Hageman Factor by di-isopropyl fluorophosphate (D.F.P.). J. Lab. clin. Med. 56: 136 1960;
4 Bell W. N, Alton H. G. A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature 174: 880 1954;
5 Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path. 6: 23 1953;
6 Biggs R, Douglas A. S, Macfarlane R. G. The initial stages of blood coagulation. J. Physiol. 122: 538 1953;
7 Biggs R, Bidwell E. The kinetics of blood thromboplastin formation. Fourth International Congress of Biochemistry, Vienna 1958. Symposion X: blood clotting factors. Pergamon Press Ltd.; 1959
8 Haanen C, Benraad H, Morselt G. Een zeldame stollingsstoornis veroorzaakt door gebrek aan Hageman-Factor. Ned. T. Geneesk. 104: 1472 1960; a
9 Haanen C, Hommes F, Benraad H, Morselt G. A case of Hageman Factor Deficiency and a Method to Purify the Factor. Thromb. Diath. haem. 5: 201 1960; b
10 Hardisty R. M, Margolis J. The role of Hageman Factor in the initiation of blood coagulation. Brit. J. Haemat. 5: 203 1959;
11 Hicks N. D, Pitney W. R. A rapid screening test for disorders of thromboplastin generation. Brit. J. Haemat. 3: 227 1957;
12 Owren P. A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 3: 201 1951;
13 Rapaport S. L, Aas K, Owren P. A. The effect of glass upon the activity of the various plasma clotting factors. J. clin. Invest. 34: 9 1955;
14 Ratnoff O. D. A familial trait characterized by deficiency of a clotpromoting fraction of plasma. J. Lab. clin. Med. 44: 915 1954;
15 Ratnoff O. D, Rosenblum J. M. Role of Hageman Factor in the iniation of clotting by glass. Amer. J. med. 25: 160 1958;
16 Shafrir E, de Vries A. Studies on the clot-promoting Activity of Glass. J. clin. Invest. 35: 1183 1956;
17 Shanberge J. N, Barias A, Regan E. The effect of protamin on thromboplastin generation. J. Lab. clin. Med. 52: 744 1958;
18 Soulier J. P, Wartelle O, Ménaché D. Hageman trait and P.T.A. deficiency. Brit. J. Haemat. 5: 121 1959;
19 Soulier J. P, Prou-Wartelle O. New data on Hageman Factor and P.T.A. Brit. J. Haemat. 6: 88 1960;
20 Waaler B. A. Contact with glass and the initial stages of intrinsic blood coagulation. Fourth International Congress of Biochemistry, Vienna 1958. Symposion X: blood clotting factors. Pergamon Press Ltd.; 1959